Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MicroRNA regulates cancer stem cells

17.12.2007
One of the biggest stories in cancer research over the past few years has been, unexpectedly, stem cells. Not embryonic stem cells, but tumor stem cells. These mutated cells, which live indefinitely and can seed new tumors, are now suspected of causing many, if not all, cancers. What is worse, these persistent cells are not killed by chemotherapy or other current treatments.

Their survival might explain why tumors frequently recur or spread after treatment. Increasingly, researchers view the challenge of getting rid of these bad seeds as the key to treating cancer far more effectively. However, because they are extremely rare, even in large tumors, studying them has been difficult.

Now, researchers have devised a way to generate large numbers of human breast cancer stem cells in mice and have discovered a genetic switch that regulates critical properties of the cells. The regulator, which belongs to a class of molecules called microRNAs (microRNAs), pushes the stem cells to become more differentiated and less tumorigenic through its ability to switch off particular genes.

“People know that microRNAs are important regulators of cell differentiation, but nobody has shown that they regulate the critical properties of cancer stem cells, or any kind of stem cells,” says Judy Lieberman, an investigator at the Immune Disease Institute and Harvard Medical School professor of pediatrics at Children’s Hospital Boston. Lieberman and Erwei Song, a former postdoc in her lab now working as a breast cancer surgeon at Sun Yat-Sen University in Guangzhou, China, are the senior investigators on the work, which appears in the Dec. 14 issue of Cell.

By showing that microRNAs can rein in tumor stem cells, the work suggests a novel way to target these cells to treat cancer with therapeutic RNAs, a promising new class of medicine under development for many diseases.

In the study, Song and first author Fengyan Yu started working in China to isolate breast cancer stem cells from freshly removed tumors. Because cancer stem cells resist chemotherapy, the researchers predicted that breast tumors from women who had received such treatment before surgery might be enriched with stem-like cells, and their experiments confirmed this idea. In tumors from untreated women, less than 1 in 250 cells had the cell surface markers and growth characteristics of stem cells; in treated tumors, the number rose to 1 in 17.

The finding gave Song and Yu the idea of trying to generate larger quantities of tumor stem cells by growing human breast cancer cells in immunosuppressed mice dosed with a chemotherapeutic agent. After three months of such a regimen, nearly 75 percent of the cells in the retrieved tumors displayed the properties of stem cells: they had the expected cell surface markers, were highly tumorigenic and metastatic in mice, were relatively drug resistant, and could be induced to differentiate into multiple kinds of breast tissue cells.

With a ready supply of cancer stem cells, the researchers were able to measure levels of microRNAs, small gene regulators that are known to influence a gene’s ability to create proteins important for cell growth and differentiation. They found that cancer stem cells contained low amounts of several microRNAs compared to more mature tumor cells or stem cells that had differentiated in culture.

They zeroed in on a tumor-supressing microRNA called let-7. When the team activated let-7 in the stem cells, they lost their ability to self-renew and began to differentiate. The cells also became less able to form tumors in mice or to metastasize. Further studies showed that let-7 did this by switching off two cancer-related genes: the oncogene Ras, and HMG2A, which when switched off caused the cells to differentiate.

If this finding applies to other tumor types, let-7 may offer a unique opportunity to attack tumor stem cells using therapeutic RNA. Delivery of the let-7 RNA to tumors could potentially deplete stem cells by pushing them down the path of differentiation. Using small RNAs to treat disease is a topic Lieberman is quite familiar with—in 2003, her lab was the first to show therapeutic RNAs could work in an animal model of liver disease, and their work has since focused on devising methods for targeting RNAs to all kinds of cells. Yu, now a visiting student in the Lieberman lab, is looking at ways to deliver the let-7 RNA mimics to stem cells.

“One of the fundamental problems of all the therapies that we have is that they are not doing anything to these cells,” Lieberman says. “If those turn out to be the cells that go on and form metastases and are resistant to chemotherapy and are responsible for relapses, and if your therapy isn’t dealing with those cells and is, in fact, selecting for them, that is very worrisome.”

David Cameron | EurekAlert!
Further information:
http://www.hms.harvard.edu
http://www.cbrinstitute.org/labs/lieberman/index.html

Further reports about: Lieberman MicroRNA RNA Regulator Stem differentiate let-7 stem cells

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>